Improving Outcomes in Systemic Lupus Erythematosus: The Importance of Access to Medications.

Systemic lupus erythematosus (SLE) is a heterogeneous autoimmune disease with the potential to affect multiple organ systems and to lead to significant morbidity and mortality. SLE disproportionately affects women and racial or ethnic minority populations, and health disparities have been described for SLE incidence, prevalence, outcomes, and mortality. 1 .